These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23243924)

  • 21. Temporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study.
    Boyd JJ; Kuisma MJ; Randell TT
    Scand J Trauma Resusc Emerg Med; 2012 Feb; 20():7. PubMed ID: 22296777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
    Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
    Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication.
    Galicia M; Dargan PI; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Wood DM; Miró Ò;
    Toxicol Lett; 2019 Oct; 314():37-42. PubMed ID: 31301370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography--mass spectrometry.
    Couper FJ; Logan BK
    J Anal Toxicol; 2000; 24(1):1-7. PubMed ID: 10654561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
    Brennan R; Van Hout MC
    J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
    Towiwat P; Phattanarudee S; Maher TJ
    Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extractionless GC/MS analysis of gamma-hydroxybutyrate and gamma-butyrolactone with trifluoroacetic anhydride and heptafluoro-1-butanol from aqueous samples.
    Sabucedo AJ; Furton KG
    J Sep Sci; 2004 Jun; 27(9):703-9. PubMed ID: 15387466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS.
    LeBeau MA; Montgomery MA; Miller ML; Burmeister SG
    J Anal Toxicol; 2000 Sep; 24(6):421-8. PubMed ID: 10999347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the date-rape drug GHB and its precursor GBL by Raman spectroscopy.
    Brewster VL; Edwards HG; Hargreaves MD; Munshi T
    Drug Test Anal; 2009 Jan; 1(1):25-31. PubMed ID: 20355156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of the interconversion of gamma-butyrolactone (GBL) to gamma hydroxybutyric acid (GHB) by Raman spectroscopy.
    Munshi T; Brewster VL; Edwards HG; Hargreaves MD; Jilani SK; Scowen IJ
    Drug Test Anal; 2013 Aug; 5(8):678-82. PubMed ID: 23225646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current knowledge on gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL) and 1 ,4-butanediol (1,4-BD)].
    Dematteis M; Pennel L; Mallaret M
    Rev Prat; 2012 May; 62(5):669-72. PubMed ID: 22730800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature.
    Shannon M; Quang LS
    Pediatr Emerg Care; 2000 Dec; 16(6):435-40. PubMed ID: 11138892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma butyrolactone (GBL) and gamma valerolactone (GVL): similarities and differences in their effects on the acoustic startle reflex and the conditioned enhancement of startle in the rat.
    Marinetti LJ; Leavell BJ; Jones CM; Hepler BR; Isenschmid DS; Commissaris RL
    Pharmacol Biochem Behav; 2012 Jun; 101(4):602-8. PubMed ID: 22349589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
    Sadasivan S; Maher TJ; Quang LS
    Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
    Liakoni E; Walther F; Nickel CH; Liechti ME
    Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High mortality rates among GHB abusers in Western Sweden.
    Knudsen K; Greter J; Verdicchio M
    Clin Toxicol (Phila); 2008 Mar; 46(3):187-92. PubMed ID: 18344100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somnophilia and Sexual Abuse through the Administration of GHB and GBL.
    Pettigrew M
    J Forensic Sci; 2019 Jan; 64(1):302-303. PubMed ID: 29783276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.